Haemodynamic effects of prenalterol in patients with coronary heart disease.
The haemodynamic effects of prenalterol, a new selective beta-1 adrenoreceptor agonist, have been studied in patients with coronary heart disease. The drug was administered intravenously in a dosage of 0.5 to 2.5 micrograms/kg body weight to 20 patients undergoing coronary angiography and to 10 pati...
Guardat en:
| Publicat a: | Br Heart J |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1980
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC482252/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6102468/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.43.2.134 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|